×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| Panacea Biotec Limited | 1,031.50 | -73.60 | 993.10 | -1.20 | 2,762 | |
| Solara Active Pharma Sciences Limited | 3490.0 | -174.3 | 3490.0 | -3.98 | 2759 | 112.0 |
| Morepen Laboratories Limited | 4879.67 | 275.09 | 4841.61 | 0.5 | 2678 | 28.9 |
Panacea Biotec Ltd., with Security Code 531349, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 95.2 | 80.4 | 56.9 | 76.6 | 108.4 | 67.9 | 112.3 | 99.3 |
| Expenses | 88.6 | 89.6 | 67.4 | 69.9 | 93.0 | 86.5 | 115.3 | 100.7 |
| Operating Profit | 6.6 | -9.2 | -10.5 | 6.7 | 15.4 | -18.6 | -3.0 | -1.4 |
| OPM % | 6.97% | -11.5% | -18.44% | 8.79% | 14.19% | -27.32% | -2.69% | -1.39% |
| Other Income | 3.1 | 16.4 | 3.8 | 3.4 | 3.3 | 6.1 | 5.0 | 3.8 |
| Interest | 3.4 | 3.4 | 3.2 | 3.8 | 3.9 | 4.6 | 6.0 | 7.0 |
| Depreciation | 5.2 | 5.1 | 5.1 | 5.1 | 5.2 | 4.9 | 4.8 | 4.9 |
| Profit before tax | 1.1 | -1.4 | -15.0 | 1.3 | 9.7 | -22.0 | -8.8 | -9.5 |
| Tax % | -59.8% | 1.5% | -8% | -0.8% | 0% | 0% | 24.2% | -22.3% |
| Net Profit | 0.4 | -1.4 | -13.8 | 1.3 | 9.7 | -12.4 | -6.7 | -7.4 |
| EPS in Rs | 0.07 | -0.22 | -2.25 | 0.21 | 1.58 | 0 | -1.09 | 0 |
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 150.5 | 136.5 | 115.7 | 147.4 | 163.5 | 132.5 | 141.1 | 165.2 |
| Expenses | 150.7 | 142.5 | 129.7 | 140.4 | 155.5 | 159.3 | 158.9 | 153.5 |
| Operating Profit | -0.2 | -6.0 | -14.0 | 7.0 | 8.0 | -26.8 | -17.8 | 11.7 |
| OPM % | -0.1% | -4.43% | -12.09% | 4.75% | 4.87% | -20.23% | -12.61% | 7.11% |
| Other Income | 8.5 | 13.6 | 6.5 | 7.4 | 6.4 | 36.3 | 9.1 | 5.1 |
| Interest | 0.9 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 2.1 | 1.9 |
| Depreciation | 9.1 | 8.8 | 8.7 | 8.7 | 9.0 | 8.4 | 8.3 | 8.5 |
| Profit before tax | -4.4 | -4.9 | -19.8 | 2.0 | 1.6 | -27.7 | -21.9 | 3.7 |
| Tax % | 33.3% | -6.1% | 6.9% | -1.1% | 1.4% | 0% | 26.9% | 40.1% |
| Net Profit | -2.2 | -2.0 | -15.9 | 4.7 | 4.4 | -2.0 | -14.0 | 3.9 |
| EPS in Rs | -0.37 | -0.23 | -2.59 | 0.77 | 0.74 | 0 | -2.27 | 0.65 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 30% |
| 3 Years: | 2% |
| TTM: | -9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 15% |
| 3 Years: | 30% |
| TTM: | 72% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 30% |
| 3 Years: | 51% |
| 1 Year: | 270% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 4% |
| 3 Years: | -4% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 22% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 30% |
| 3 Years: | 51% |
| 1 Year: | 270% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|